Citadel Advisors’s BrightSpring Health Services BTSG Stock Holding History

Citadel Advisors’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66M	Buy	38,200 +4,400	+13%	+$244K	﹤0.01%	5925
2026 Q1	$1.44M	Buy	33,800 +5,700	+20%	+$230K	﹤0.01%	6809
2025 Q4	$1.05M	Buy	28,100 +1,200	+4%	+$40.2K	﹤0.01%	7282
2025 Q3	$795K	Buy	26,900 +13,700	+104%	+$318K	﹤0.01%	8040
2025 Q2	$311K	Buy	13,200 +3,700	+39%	+$77.2K	﹤0.01%	9730
2025 Q1	$172K	Buy	9,500 +600	+7%	+$11.8K	﹤0.01%	10668
2024 Q4	$152K	Sell	8,900 -400	-4%	-$6.92K	﹤0.01%	10872
2024 Q3	$137K	Buy	9,300 +7,400	+389%	+$92.7K	﹤0.01%	10686
2024 Q2	$21.6K	Sell	1,900 -700	-27%	-$7.64K	﹤0.01%	12563
2024 Q1	$28.3K	Buy	+2,600	New	+$26K	﹤0.01%	12749

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's BTSG Position: Q2 2026 in Review

Citadel Advisors reduced its BrightSpring Health Services (BTSG) stake by 83% in Q2 2026, selling an estimated $143M and leaving 517,146 shares worth $36.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Citadel Advisors first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. The position peaked at $132M in Q1 2026. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

Citadel Advisors held 517,146 shares of BrightSpring Health Services worth $36.1M as of Q2 2026.
Citadel Advisors sold 2,570,778 BrightSpring Health Services shares in Q2 2026, an estimated $143M.
BrightSpring Health Services made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #1892 holding.
Citadel Advisors first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
Citadel Advisors's BrightSpring Health Services position peaked at $132M in Q1 2026.
423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.